# Activated astrocytes increase dehydroascorbic acid uptake, changing intracellular metabolism and vitamin C recycling and emulating neuropathological conditions

**Authors:** Pedro Cisternas, Katterine Salazar, Eder Ramírez, Sebastián Elgueta, Isabelle de Lima, Valentina Muñoz, Francisco Nualart

PMC · DOI: 10.1016/j.redox.2026.104074 · Redox Biology · 2026-02-09

## TL;DR

This study shows how vitamin C recycling in astrocytes changes with age, affecting brain cell metabolism and antioxidant defenses.

## Contribution

The paper introduces a cellular model of reactive astrocytes with impaired vitamin C recycling and altered metabolic functions.

## Key findings

- 30-day-old astrocytes show reduced efficiency in recycling vitamin C and altered redox metabolism.
- DHA accumulation in activated astrocytes inhibits the pentose phosphate pathway and reduces glutathione levels.
- DHA stimulates lactate uptake mainly in younger astrocytes (15 days in vitro).

## Abstract

Oxidative damage in neurodegenerative diseases activates astrocytes and perturbs antioxidant defenses. Vitamin C is the principal antioxidant in the brain. Ascorbic acid (AA, reduced form) is taken up by neurons via the sodium/vitamin C transporter 2 (SVCT2). Astrocytes take up only the oxidized form of vitamin C, dehydroascorbic acid (DHA), through glucose transporters (GLUT). AA is recycled between neurons and astrocytes, preserving antioxidant capacity and maintaining physiological DHA levels. We postulate that AA recycling modulates astrocyte energy and redox metabolism. We therefore examined the effects of AA and DHA accumulation on glycolysis, pentose phosphate pathway (PPP) activity, and glutathione (GSH) concentrations in activated astrocytes. Culture time negatively modulated DHA recycling. At 15 days in vitro (DIV), astrocytes efficiently took up physiological DHA and reduced it to AA, enhancing redox metabolism, stimulating PPP activity, and increasing intracellular GSH. At 30 DIV (cells positive for activation markers), astrocytes took up higher amounts of DHA but reduced it inefficiently; at this time point, the glycolytic rate was unchanged, PPP activity was inhibited, and GSH decreased. In both 15- and 30-DIV astrocytes, DHA stimulated lactate uptake. We propose that 30-DIV astrocytes constitute a cellular model of reactive astrocytes with impaired AA recycling, ultimately altering glycolytic and antioxidant function.

Image 1

•Vitamin C recycling modulates astrocyte energy and redox metabolism.•30-DIV astrocytes constitute a cellular model of reactive astrocytes with reduced AA recycling.•DHA accumulation alters glycolysis, PPP activity, and GSH levels in activated (30-DIV) astrocytes.•DHA stimulates lactate uptake predominantly in 15-DIV astrocytes.

Vitamin C recycling modulates astrocyte energy and redox metabolism.

30-DIV astrocytes constitute a cellular model of reactive astrocytes with reduced AA recycling.

DHA accumulation alters glycolysis, PPP activity, and GSH levels in activated (30-DIV) astrocytes.

DHA stimulates lactate uptake predominantly in 15-DIV astrocytes.

## Linked entities

- **Proteins:** SLC23A2 (solute carrier family 23 member 2), SLC2A1 (solute carrier family 2 member 1), LOC23687505 (pyrimidodiazepine synthase)
- **Chemicals:** vitamin C (PubChem CID 54670067), ascorbic acid (PubChem CID 9888239), dehydroascorbic acid (PubChem CID 440667), DHA (PubChem CID 15608515), lactate (PubChem CID 61503)

## Full-text entities

- **Genes:** SLC1A3 (solute carrier family 1 member 3) [NCBI Gene 403748] {aka GLAST}, SLC2A3 (solute carrier family 2 member 3) [NCBI Gene 403997] {aka GLUT3}, GFAP (glial fibrillary acidic protein) [NCBI Gene 480495], MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, VIM (vimentin) [NCBI Gene 7431], glucose-6-phosphate dehydrogenase [NCBI Gene 481088], SLC23A2 (solute carrier family 23 member 2) [NCBI Gene 403490] {aka SVCT2}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 403755], H6PD (hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase) [NCBI Gene 9563] {aka CORTRD1, G6PDH, GDH, H6PDH}, SLC2A3 (solute carrier family 2 member 3) [NCBI Gene 6515] {aka GLUT3}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 403871] {aka K-RAS}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 475526], SLC23A2 (solute carrier family 23 member 2) [NCBI Gene 9962] {aka NBTL1, SLC23A1, SVCT2, YSPL2}, MAP2 (microtubule associated protein 2) [NCBI Gene 488504], VIM (vimentin) [NCBI Gene 477991]
- **Diseases:** PD (MESH:D010300), ischemia (MESH:D007511), colon cancer (MESH:D015179), neurodegenerative diseases (MESH:D019636), brain injury (MESH:D001930), leukemic (MESH:D007938), AD (MESH:D000544), ALS (MESH:D000690), cervical dislocation (MESH:D002575), glioblastoma (MESH:D005909)
- **Chemicals:** MgCl2 (MESH:D015636), SDS (MESH:D012967), paraformaldehyde (MESH:C003043), DHA (MESH:D003683), CaCl2 (MESH:D002122), trichloroacetic acid (MESH:D014238), Fungizone (MESH:D000666), EDTA (MESH:D004492), pentose phosphate (MESH:D010428), HEPES (MESH:D006531), Alexa Fluor 647 (MESH:C569686), NADP (MESH:D009249), 2-vinylpyridine (MESH:C030953), 2-DOG (MESH:D003847), streptomycin (MESH:D013307), Tris-phosphate (MESH:C005692), cytochalasin B (MESH:D003571), sulfosalicylic acid (MESH:C003366), Krebs-Henseleit buffer (MESH:C074097), 4-alphaCIN (-), MgSO4 (MESH:D008278), lactate (MESH:D019344), oxygen (MESH:D010100), cytochalasin E (MESH:C007215), l-glutamine (MESH:D005973), KCl (MESH:D011189), thiol (MESH:D013438), HCl (MESH:D006851), sucrose (MESH:D013395), glucose-6-phosphate (MESH:D019298), LPS (MESH:D008070), ATP (MESH:D000255), AA (MESH:D001205), 1,4-dithiothreitol (MESH:D004229), silica (MESH:D012822), NaCl (MESH:D012965), Glucose (MESH:D005947), Hoechst 33342 (MESH:C017807), GSSG (MESH:D019803), Na+ (MESH:D012964), ROS (MESH:D017382), K2HPO4 (MESH:C013216), phosphate (MESH:D010710), methanol (MESH:D000432), Glutamate (MESH:D018698), penicillin (MESH:D010406), PBS (MESH:D007854), pepstatin A (MESH:C031375), cysteine (MESH:D003545), HgCl2 (MESH:D008627), GSH (MESH:D005978)
- **Species:** Homo sapiens (human, species) [taxon 9606], Gallus gallus (bantam, species) [taxon 9031], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** G712A, E in 15, C in 0, C in 15

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996795/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12996795/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12996795/full.md

---
Source: https://tomesphere.com/paper/PMC12996795